![Benjamin Scruggs](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Benjamin Scruggs
Directeur Général chez Altis Biosystems, Inc.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Michael Biron | M | - |
Altis Biosystems, Inc.
![]() Altis Biosystems, Inc. Miscellaneous Commercial ServicesCommercial Services Altis Biosystems, Inc. operates as a biotechnology company. It develops patent-pending stem cell technology that recreates the human intestinal epithelium. The firm offers products such as RepliGut Planar and RepliGut Crypt. The company was founded by Michael Biron, Christopher Sims, Nancy Allbritton, Scott Magness and Yuli Wang and is headquarterd in Chapel Hill, NC. | - |
Anil K. Goyal | M | 59 |
IMMvention Therapeutix, Inc.
![]() IMMvention Therapeutix, Inc. BiotechnologyHealth Technology IMMvention Therapeutix, Inc. is an American biotechnology company that develops therapies. The company was founded by Jenny Ting and the CEO is Anil K. Goyal. | - |
Charles A. Gersbach | M | - |
Tune Therapeutics, Inc.
![]() Tune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tune Therapeutics, Inc. is a genetic medicine company based in Durham, NC. Tune Therapeutics is pioneering a new therapeutic modality with its versatile and powerful tempo epigenomic control platform. The platform has the potential to fine-tune any gene network and unlock the full power and potential of regenerative medicine. The company is driving through an inflection point in the history of genetic medicine by addressing thousands of common and complex diseases for which no curative treatment is available. Tune Therapeutics pioneers next-generation genetic therapies by exploring epigenomic control for discovering novel targets that are inaccessible to other approaches. The company was founded in 2020 by Fyodor Urnov, Akira Matsuno, Charles A. Gersbach. The CEO is Matt Kane. | - |
Akira Matsuno | M | - |
Tune Therapeutics, Inc.
![]() Tune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tune Therapeutics, Inc. is a genetic medicine company based in Durham, NC. Tune Therapeutics is pioneering a new therapeutic modality with its versatile and powerful tempo epigenomic control platform. The platform has the potential to fine-tune any gene network and unlock the full power and potential of regenerative medicine. The company is driving through an inflection point in the history of genetic medicine by addressing thousands of common and complex diseases for which no curative treatment is available. Tune Therapeutics pioneers next-generation genetic therapies by exploring epigenomic control for discovering novel targets that are inaccessible to other approaches. The company was founded in 2020 by Fyodor Urnov, Akira Matsuno, Charles A. Gersbach. The CEO is Matt Kane. | - |
Christopher Sims | M | - |
Altis Biosystems, Inc.
![]() Altis Biosystems, Inc. Miscellaneous Commercial ServicesCommercial Services Altis Biosystems, Inc. operates as a biotechnology company. It develops patent-pending stem cell technology that recreates the human intestinal epithelium. The firm offers products such as RepliGut Planar and RepliGut Crypt. The company was founded by Michael Biron, Christopher Sims, Nancy Allbritton, Scott Magness and Yuli Wang and is headquarterd in Chapel Hill, NC. | - |
Matthew B. Boxer | M | - |
Veralox Therapeutics, Inc.
![]() Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | 7 ans |
Mike Dial | M | - |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | 15 ans |
Clay Thorp | M | 55 |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | 24 ans |
John Crumpler | M | - |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | 24 ans |
Kseniya Simpson | M | - |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | 5 ans |
David J. Maloney | M | - |
Veralox Therapeutics, Inc.
![]() Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | 7 ans |
Scott Magness | M | - |
Altis Biosystems, Inc.
![]() Altis Biosystems, Inc. Miscellaneous Commercial ServicesCommercial Services Altis Biosystems, Inc. operates as a biotechnology company. It develops patent-pending stem cell technology that recreates the human intestinal epithelium. The firm offers products such as RepliGut Planar and RepliGut Crypt. The company was founded by Michael Biron, Christopher Sims, Nancy Allbritton, Scott Magness and Yuli Wang and is headquarterd in Chapel Hill, NC. | - |
Jenny Ting | M | - |
IMMvention Therapeutix, Inc.
![]() IMMvention Therapeutix, Inc. BiotechnologyHealth Technology IMMvention Therapeutix, Inc. is an American biotechnology company that develops therapies. The company was founded by Jenny Ting and the CEO is Anil K. Goyal. | - |
Matt Kane | M | - |
Tune Therapeutics, Inc.
![]() Tune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tune Therapeutics, Inc. is a genetic medicine company based in Durham, NC. Tune Therapeutics is pioneering a new therapeutic modality with its versatile and powerful tempo epigenomic control platform. The platform has the potential to fine-tune any gene network and unlock the full power and potential of regenerative medicine. The company is driving through an inflection point in the history of genetic medicine by addressing thousands of common and complex diseases for which no curative treatment is available. Tune Therapeutics pioneers next-generation genetic therapies by exploring epigenomic control for discovering novel targets that are inaccessible to other approaches. The company was founded in 2020 by Fyodor Urnov, Akira Matsuno, Charles A. Gersbach. The CEO is Matt Kane. | - |
Nancy Thornberry | F | 67 |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | - |
John McHutchison | M | 66 |
Tune Therapeutics, Inc.
![]() Tune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tune Therapeutics, Inc. is a genetic medicine company based in Durham, NC. Tune Therapeutics is pioneering a new therapeutic modality with its versatile and powerful tempo epigenomic control platform. The platform has the potential to fine-tune any gene network and unlock the full power and potential of regenerative medicine. The company is driving through an inflection point in the history of genetic medicine by addressing thousands of common and complex diseases for which no curative treatment is available. Tune Therapeutics pioneers next-generation genetic therapies by exploring epigenomic control for discovering novel targets that are inaccessible to other approaches. The company was founded in 2020 by Fyodor Urnov, Akira Matsuno, Charles A. Gersbach. The CEO is Matt Kane. | 1 ans |
Fred Goldwater | M | - |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | 13 ans |
John Lepore | M | - |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | - |
Kevin Clark | M | 68 |
Vanderbilt University
| 22 ans |
Parker Johnson | M | - |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | 3 ans |
Jeff Terrell | M | - |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | 12 ans |
Lauren Flickinger | F | - |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | 3 ans |
Jim Trenkle | M | - |
Veralox Therapeutics, Inc.
![]() Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | - |
Yury Kukushkin | M | - |
Veralox Therapeutics, Inc.
![]() Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | 4 ans |
Dan McHugh | M | - |
Tune Therapeutics, Inc.
![]() Tune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tune Therapeutics, Inc. is a genetic medicine company based in Durham, NC. Tune Therapeutics is pioneering a new therapeutic modality with its versatile and powerful tempo epigenomic control platform. The platform has the potential to fine-tune any gene network and unlock the full power and potential of regenerative medicine. The company is driving through an inflection point in the history of genetic medicine by addressing thousands of common and complex diseases for which no curative treatment is available. Tune Therapeutics pioneers next-generation genetic therapies by exploring epigenomic control for discovering novel targets that are inaccessible to other approaches. The company was founded in 2020 by Fyodor Urnov, Akira Matsuno, Charles A. Gersbach. The CEO is Matt Kane. | - |
Cohen Matthew | M | - |
IMMvention Therapeutix, Inc.
![]() IMMvention Therapeutix, Inc. BiotechnologyHealth Technology IMMvention Therapeutix, Inc. is an American biotechnology company that develops therapies. The company was founded by Jenny Ting and the CEO is Anil K. Goyal. | - |
Myla Lai Goldman | F | - |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | - |
Lev Osherovich | M | - |
IMMvention Therapeutix, Inc.
![]() IMMvention Therapeutix, Inc. BiotechnologyHealth Technology IMMvention Therapeutix, Inc. is an American biotechnology company that develops therapies. The company was founded by Jenny Ting and the CEO is Anil K. Goyal. | - |
Charlie Sanders | M | 91 |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | - |
Ali Behbahani | M | 45 |
Tune Therapeutics, Inc.
![]() Tune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tune Therapeutics, Inc. is a genetic medicine company based in Durham, NC. Tune Therapeutics is pioneering a new therapeutic modality with its versatile and powerful tempo epigenomic control platform. The platform has the potential to fine-tune any gene network and unlock the full power and potential of regenerative medicine. The company is driving through an inflection point in the history of genetic medicine by addressing thousands of common and complex diseases for which no curative treatment is available. Tune Therapeutics pioneers next-generation genetic therapies by exploring epigenomic control for discovering novel targets that are inaccessible to other approaches. The company was founded in 2020 by Fyodor Urnov, Akira Matsuno, Charles A. Gersbach. The CEO is Matt Kane. | - |
Donald Rose | M | - |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | 5 ans |
Jamie Stiff | M | - |
Veralox Therapeutics, Inc.
![]() Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | - |
William Hawkins | M | 70 |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | - |
Craig J. Nickels | M | - |
Washington University in St. Louis
| 17 ans |
John Alston Gardner | M | - |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | 7 ans |
Susan Mahony | M | 59 |
Altis Biosystems, Inc.
![]() Altis Biosystems, Inc. Miscellaneous Commercial ServicesCommercial Services Altis Biosystems, Inc. operates as a biotechnology company. It develops patent-pending stem cell technology that recreates the human intestinal epithelium. The firm offers products such as RepliGut Planar and RepliGut Crypt. The company was founded by Michael Biron, Christopher Sims, Nancy Allbritton, Scott Magness and Yuli Wang and is headquarterd in Chapel Hill, NC. | - |
Arnold Levine | M | 84 |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | - |
Herb Boyer | M | 87 |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | - |
Douglas Reed | M | 70 |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | 17 ans |
Christy Shaffer | M | 66 |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | 8 ans |
Myla Lai-Goldman | M | 66 |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | 13 ans |
Kenneth Lee | M | 76 |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | 21 ans |
Scott M. Albert | M | - |
Altis Biosystems, Inc.
![]() Altis Biosystems, Inc. Miscellaneous Commercial ServicesCommercial Services Altis Biosystems, Inc. operates as a biotechnology company. It develops patent-pending stem cell technology that recreates the human intestinal epithelium. The firm offers products such as RepliGut Planar and RepliGut Crypt. The company was founded by Michael Biron, Christopher Sims, Nancy Allbritton, Scott Magness and Yuli Wang and is headquarterd in Chapel Hill, NC. | 7 ans |
Joseph T. McMahon | M | - |
Altis Biosystems, Inc.
![]() Altis Biosystems, Inc. Miscellaneous Commercial ServicesCommercial Services Altis Biosystems, Inc. operates as a biotechnology company. It develops patent-pending stem cell technology that recreates the human intestinal epithelium. The firm offers products such as RepliGut Planar and RepliGut Crypt. The company was founded by Michael Biron, Christopher Sims, Nancy Allbritton, Scott Magness and Yuli Wang and is headquarterd in Chapel Hill, NC. | 4 ans |
Jonathan Mow | M | 59 |
Veralox Therapeutics, Inc.
![]() Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | 1 ans |
Mark Velleca | M | 60 |
IMMvention Therapeutix, Inc.
![]() IMMvention Therapeutix, Inc. BiotechnologyHealth Technology IMMvention Therapeutix, Inc. is an American biotechnology company that develops therapies. The company was founded by Jenny Ting and the CEO is Anil K. Goyal. | - |
Alex Martin Martin | M | 55 |
Veralox Therapeutics, Inc.
![]() Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | 4 ans |
Peter Young | M | 74 |
Veralox Therapeutics, Inc.
![]() Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | 1 ans |
Fred Gage | M | - |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | - |
Nancy Hutson | M | 74 |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | - |
H. Thorp | M | - |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | 18 ans |
Martin Murphy | M | 81 |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | - |
Joseph DeSimone | M | - |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | - |
Joe C. Cook | M | 82 |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | - |
Richard Flavell | M | - |
Hatteras Venture Partners
![]() Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Joshua Chan | M | - |
Washington University in St. Louis
| 4 ans |
Kimberly Walker | F | 65 |
Washington University in St. Louis
| 10 ans |
Pramila Agrawal | M | - |
Vanderbilt University
| 4 ans |
August Haug | M | - |
Washington University in St. Louis
| 13 ans |
Kendra Perlitz | F | - |
Vanderbilt University
| 5 ans |
Guan Dong Wang | M | 50 |
Washington University in St. Louis
| 3 ans |
Su Ying Liu | M | 35 |
Washington University in St. Louis
| 6 ans |
Doug Benowitz | M | - |
Washington University in St. Louis
| 4 ans |
James Cuber | M | - |
Washington University in St. Louis
| 4 ans |
Trevor Breen | M | - |
Vanderbilt University
| 5 ans |
Louis Hsu | M | - |
Washington University in St. Louis
| 4 ans |
Nick Vom Brack | M | - |
Washington University in St. Louis
| 6 ans |
Mike Torney | M | - |
Washington University in St. Louis
| 4 ans |
Keryn Gold | M | - |
Washington University in St. Louis
| 9 ans |
Michael Nelson | M | 69 |
Vanderbilt University
| 2 ans |
Eric Pownall Billings | M | - |
Vanderbilt University
| 6 ans |
Tayler Gudeman | F | - |
Vanderbilt University
| 5 ans |
Adi Agrawal | M | - |
Vanderbilt University
| 4 ans |
George Sibble | M | - |
Vanderbilt University
| 6 ans |
Ryan Wood | M | - |
Vanderbilt University
| 4 ans |
Bharath Subramanian | M | - |
Vanderbilt University
| 4 ans |
Paul K. Hepper | M | - |
Vanderbilt University
| 4 ans |
Pete K. Kostiuk | M | - |
Vanderbilt University
| 4 ans |
Jay A. Webb | M | - |
Vanderbilt University
| 4 ans |
Laura Hershenow | F | - |
Vanderbilt University
| 3 ans |
Nicholas B. Ogden | M | - |
Vanderbilt University
| 4 ans |
Dan Margolis | M | - |
Washington University in St. Louis
| 4 ans |
Lara Bes | F | - |
Washington University in St. Louis
| 4 ans |
Tracey Jackson | F | - |
Washington University in St. Louis
| 4 ans |
Michael Cohen | M | - |
Washington University in St. Louis
| 4 ans |
Nick Matthew Zager | M | - |
Vanderbilt University
| 2 ans |
Kate Grafstein | F | - |
Washington University in St. Louis
| 4 ans |
Mark R. Mason | M | - |
Vanderbilt University
| 4 ans |
Paul Grayson | M | - |
Vanderbilt University
| 4 ans |
Aviel Ginzburg | M | - |
Vanderbilt University
| 4 ans |
Stephen A. Bansak | M | - |
Vanderbilt University
| 4 ans |
Michael Phipps | M | - |
Vanderbilt University
| 4 ans |
Christopher Grambling | M | - |
Vanderbilt University
| 4 ans |
Richard Aloysius Finch | M | - |
Vanderbilt University
| 2 ans |
Brian Bourgeois | M | - |
Vanderbilt University
| 4 ans |
Paige Daniel | F | - |
Vanderbilt University
| 4 ans |
Jason Power | M | - |
Vanderbilt University
| 4 ans |
Rhett Morris | M | - |
Vanderbilt University
| 2 ans |
Richard E. Goldstein | M | - |
Vanderbilt University
| 5 ans |
Alex Tannenbaum | M | - |
Washington University in St. Louis
| 4 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 100 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Benjamin Scruggs
- Réseau Personnel